It is 20% of 2019 performance. Aristo is a 3 million AUD EBITDA per quarter asset.
It will be a good sign if the group can recover to 4.5-5 million per quarter by end of this quarter
It will be on more solid footing when cash balance reaching 30 million AUD, which is enough to cover the loans and the potential tax liabilities.
Don't see that happening for another 12 months to be frank.
So I don't see there will be major rerating over the peak since covid
- Forums
- ASX - By Stock
- DNA
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNA (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.53M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.2¢ | $1.95K | 60.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 240228 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 597415 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 240228 | 0.032 |
2 | 41150 | 0.031 |
3 | 91670 | 0.030 |
5 | 450740 | 0.029 |
2 | 138751 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 597415 | 1 |
0.034 | 13000 | 1 |
0.035 | 6986 | 1 |
0.038 | 800000 | 1 |
0.039 | 274868 | 5 |
Last trade - 14.56pm 26/06/2024 (20 minute delay) ? |
Featured News
DNA (ASX) Chart |